Your session is about to expire
← Back to Search
Remote Patient Monitoring
Effects of Remote Patient Monitoring on Chronic Disease Management
N/A
Waitlist Available
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 6 months
Awards & highlights
No Placebo-Only Group
Summary
Remote patient monitoring is a potential component for the management of chronic conditions that may provide reliable and real-time physiological measurements for clinical decision support, alerting, and patient self-management. The purpose of this study is to evaluate an UHN-built remote monitoring system for patients with complex chronic conditions called Medly.
Eligible Conditions
- Heart Failure
- Chronic Kidney Disease
- Chronic Obstructive Pulmonary Disease
- Diabetes
- High blood pressure
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 6 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Quality of Life as Measured by SF-36
Secondary study objectives
Anxiety and Depression as Measured by HADS
Heart-failure Specific Quality of Life (MLHFQ)
Self-Care of Health Failure as Measured by the SCHFI
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Telemonitoring (Medly)Experimental Treatment1 Intervention
The telemonitoring technology will enable patients with complex chronic illnesses, to take clinically relevant physiological measurements with wireless home medical devices and to answer symptom questions on the mobile phone. The measurements will be automatically and wirelessly transmitted to the mobile phone and then to a data server. Automated self-care instructions/messages will be sent to the patient based on the readings and reported symptoms. If there are signs of their status deteriorating, an alert will be sent to a clinician that is responsible for the particular chronic condition of concern. The clinicians will have all the relevant patient data sent to them and will be able to access (through a secure web portal) to view historical and trending data for their patients.
Group II: ControlActive Control1 Intervention
Standard of care: Patients are followed in a specialty care clinic treating their primary conditions. Patients typically have scheduled appointments every six months.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Medly
2016
N/A
~100
Find a Location
Who is running the clinical trial?
University Health Network, TorontoLead Sponsor
1,531 Previous Clinical Trials
504,226 Total Patients Enrolled
26 Trials studying Heart Failure
17,425 Patients Enrolled for Heart Failure